Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 95, Issue 5, Pages 496-498Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/clpt.2014.17
Keywords
-
Categories
Funding
- Clinical and Translational Science Award program, through the National Institutes of Health (NIH) National Center for Advancing Translational Sciences [UL1TR000427]
Ask authors/readers for more resources
The US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) is a database for postmarketing drug safety monitoring and influences changes in FDA safety guidance documents such as drug labels. The number of cases in the FAERS has rapidly increased with the improvement of submission methods and data standards and thus has become an important resource for regulatory science. Although the FAERS has been predominantly used for safety signal detection, this study explored its utility for disease characteristics.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available